Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18919170 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | October 2024 | August 2025 | Abandon | 10 | 0 | 1 | No | No |
| 18889250 | METHOD TO CHARACTERIZE NUCLEIC ACID | September 2024 | January 2026 | Abandon | 16 | 2 | 0 | Yes | No |
| 18763579 | METHODS OF CAPTURING TARGET ANALYTES | July 2024 | July 2025 | Abandon | 13 | 2 | 0 | No | No |
| 18412111 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | January 2024 | January 2025 | Abandon | 12 | 1 | 0 | No | No |
| 18410474 | METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | January 2024 | May 2025 | Abandon | 16 | 2 | 0 | No | No |
| 18537520 | METHODS, PROBE SETS, AND KITS FOR DETECTION OF DELETION OF TUMOR SUPPRESSOR GENES BY FLUORESCENCE IN SITU HYBRIDIZATION | December 2023 | December 2025 | Abandon | 24 | 3 | 1 | Yes | No |
| 18517524 | DNA LOCATION METHOD AND APPARATUS | November 2023 | April 2025 | Abandon | 17 | 3 | 0 | No | Yes |
| 18457770 | METHODS FOR EARLY DETECTION OF CANCER | August 2023 | June 2025 | Abandon | 21 | 1 | 0 | No | No |
| 18336450 | CONTROLS FOR PROXIMITY DETECTION ASSAYS | June 2023 | October 2025 | Abandon | 28 | 4 | 0 | Yes | Yes |
| 18311644 | COMPOSITIONS AND METHODS FOR BINDING AN ANALYTE TO A CAPTURE PROBE | May 2023 | October 2024 | Abandon | 17 | 2 | 0 | No | No |
| 18309128 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | April 2023 | September 2024 | Allow | 17 | 3 | 1 | Yes | No |
| 18309116 | MANIPULATING AND DETECTING BIOLOGICAL SAMPLES | April 2023 | May 2025 | Abandon | 24 | 4 | 0 | No | Yes |
| 18131128 | METHOD COMBINING IN SITU TARGET CAPTURE AND SPATIAL UNIQUE MOLECULAR IDENTIFIER (SUMI) IDENTIFICATION WITH IN VITRO SEQUENCING FOR HIGH DENSITY SPATIAL MULTIOMICS | April 2023 | March 2026 | Abandon | 35 | 1 | 0 | No | No |
| 18023257 | METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | February 2023 | March 2026 | Abandon | 37 | 1 | 0 | No | No |
| 18022098 | HYBRIDISATION-BASED SENSOR SYSTEMS AND PROBES | February 2023 | February 2026 | Abandon | 36 | 1 | 0 | No | No |
| 18161581 | MULTIPLEXED COVID-19 PADLOCK ASSAY | January 2023 | February 2026 | Abandon | 37 | 1 | 0 | No | No |
| 18068157 | NOVEL ADAPTOR FOR NUCLEIC ACID SEQUENCING AND METHOD OF USE | December 2022 | January 2026 | Abandon | 37 | 5 | 0 | No | No |
| 17991429 | SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCING | November 2022 | February 2025 | Abandon | 27 | 1 | 1 | No | No |
| 18049925 | METHODS FOR REMOVAL OF ADAPTOR DIMERS FROM NUCLEIC ACID SEQUENCING PREPARATIONS | October 2022 | October 2025 | Allow | 36 | 3 | 0 | No | No |
| 17957999 | MULTIOMIC ANALYSIS DEVICE AND METHODS OF USE THEREOF | September 2022 | November 2024 | Abandon | 25 | 4 | 1 | Yes | Yes |
| 17933347 | METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE | September 2022 | November 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17863842 | METHODS FOR IMPROVING SPATIAL PERFORMANCE | July 2022 | January 2026 | Abandon | 42 | 1 | 0 | No | No |
| 17861218 | DNA LOCATION METHOD AND APPARATUS | July 2022 | May 2025 | Allow | 34 | 4 | 0 | Yes | Yes |
| 17811192 | CALIBRATION PANELS AND METHODS FOR DESIGNING THE SAME | July 2022 | March 2025 | Abandon | 32 | 2 | 0 | Yes | No |
| 17809540 | METHODS FOR ATTACHING ADAPTERS TO SAMPLE NUCLEIC ACIDS | June 2022 | October 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17837254 | NUCLEIC ACID DETECTION METHOD | June 2022 | May 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17694423 | LOCKED NUCLEIC ACIDS FOR CAPTURING FUSION GENES | March 2022 | February 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17685016 | ANALYTE DETECTION IN SITU USING NUCLEIC ACID ORIGAMI | March 2022 | October 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17635424 | LIVE CELL IMAGING OF NON-REPETITIVE GENOMIC LOCI | February 2022 | March 2026 | Abandon | 49 | 0 | 1 | No | No |
| 17590200 | METHODS AND NUCLEIC ACIDS FOR THE DETECTION OF COLORECTAL CELL PROLIFERATIVE DISORDERS | February 2022 | May 2025 | Abandon | 39 | 1 | 1 | No | No |
| 17530932 | PHOTO-TRIGGERED NUCLEIC ACID CONSTRUCTS AND METHODS FOR MOLECULAR DETECTION | November 2021 | September 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17601464 | GENETIC VARIANTS ASSOCIATED WITH RESPONSE TO TREATMENT OF NEUROLOGICAL DISORDERS | October 2021 | May 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17438579 | DETECTION OF DOUBLE STRANDED NUCLEIC ACIDS IN SITU AND METHODS RELATED THERETO | September 2021 | April 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17436161 | MACROPHAGE EXPRESSION IN BREAST CANCER | September 2021 | April 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17461816 | METHOD OF CALIBRATION OF MFISH USING SLIDES | August 2021 | March 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17431488 | IMPROVED NUCLEIC ACID TARGET ENRICHMENT AND RELATED METHODS | August 2021 | October 2025 | Abandon | 50 | 1 | 1 | No | No |
| 17370859 | COMPOSITIONS AND METHODS FOR DETECTING VIRAL NUCLEIC ACIDS | July 2021 | August 2025 | Allow | 50 | 3 | 0 | No | Yes |
| 17362828 | IN SITU DETECTION OF NUCLEOTIDE VARIANTS IN HIGH NOISE SAMPLES, AND COMPOSITIONS AND METHODS RELATED THERETO | June 2021 | November 2024 | Abandon | 40 | 2 | 0 | No | No |
| 17418660 | METHOD FOR QUICKLY EXTRACTING LONG-FRAGMENT GENOMIC DNA BY SINGLE REACTION TUBE, AND KIT | June 2021 | January 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17416510 | Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA | June 2021 | January 2026 | Abandon | 55 | 1 | 0 | No | No |
| 17416207 | METHOD OF DETECTING INFECTION WITH PATHOGENS CAUSING TUBERCULOSIS | June 2021 | November 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17291739 | METHOD FOR DETECTING GENOME-RELATED INFORMATION OF CELL COEXISTING WITH AT LEAST ONE TYPE OF TEST SUBSTANCE | June 2021 | March 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17312638 | THREE-DIMENSIONAL SPATIAL ANALYSIS | June 2021 | August 2025 | Abandon | 50 | 1 | 0 | No | No |
| 17299728 | SYSTEMS FOR PROTEIN-PROTEIN INTERACTION SCREENING | June 2021 | February 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17288283 | UNIVERSAL METHOD FOR EXTRACTING NUCLEIC ACID MOLECULES FROM A DIVERSE POPULATION OF MICROBES | April 2021 | January 2026 | Abandon | 57 | 0 | 1 | No | No |
| 17183824 | DUAL QUENCHING ASSAY FOR MULTIPLEX DETECTION OF TARGET NUCLEIC ACIDS | February 2021 | November 2024 | Abandon | 45 | 2 | 1 | No | No |
| 17172553 | NANOPORE DEVICE AND METHODS OF DETECTING AND CLASSIFYING CHARGED PARTICLES USING SAME | February 2021 | May 2025 | Abandon | 51 | 2 | 0 | No | No |
| 16625486 | METHOD FOR PURIFYING TOTAL MRNA FROM TOTAL RNA USING SLFN13 | October 2020 | January 2025 | Abandon | 60 | 2 | 0 | Yes | No |
| 16963591 | MULTIMERIC POLYNUCLEOTIDES AND USES THEREOF | July 2020 | August 2025 | Abandon | 60 | 0 | 2 | No | No |
| 16920269 | PHOSPHATIDIC ACID SENSOR | July 2020 | May 2025 | Abandon | 58 | 4 | 0 | Yes | No |
| 16892826 | METHODS OF DETECTING NUCLEIC ACID SEQUENCES WITH HIGH SPECIFICITY | June 2020 | January 2025 | Abandon | 55 | 4 | 0 | Yes | No |
| 16881387 | ENHANCED METHODS OF RIBONUCLEIC ACID HYBRIDIZATION | May 2020 | August 2025 | Abandon | 60 | 6 | 0 | No | No |
| 16758217 | SINGLE NUCLEOTIDE ANALYTICAL METHOD AND ASSOCIATED PROBES | April 2020 | November 2025 | Abandon | 60 | 5 | 0 | Yes | No |
| 16854618 | HYBRIDIZATION COMPOSITIONS AND METHODS FOR MAKING AND USING COMPOSITIONS | April 2020 | May 2025 | Allow | 60 | 3 | 1 | No | No |
| 16626751 | DNA PRODUCTION METHOD AND DNA FRAGMENT-JOINING KIT | December 2019 | October 2025 | Abandon | 60 | 5 | 0 | Yes | No |
| 16532396 | USE OF ENZYMES FOR ALTERING RATIOS OF PARTIALLY MATCHED POLYNUCLEOTIDES | August 2019 | November 2024 | Abandon | 60 | 3 | 1 | No | No |
| 16334708 | METHOD FOR LABELING OLIGONUCLEOTIDE PROBES | March 2019 | September 2025 | Abandon | 60 | 6 | 1 | Yes | Yes |
| 16170863 | QUALITY EVALUATION METHOD, QUALITY EVALUATION APPARATUS, PROGRAM, STORAGE MEDIUM, AND QUALITY CONTROL SAMPLE | October 2018 | February 2025 | Abandon | 60 | 5 | 1 | Yes | No |
| 16142845 | CHROMOSOMAL ANALYSIS BY MOLECULAR KARYOTYPING | September 2018 | August 2024 | Allow | 60 | 2 | 1 | Yes | Yes |
| 15752505 | COMPOSITION AND METHODS FOR HYBRIDIZATION | February 2018 | February 2026 | Allow | 60 | 8 | 0 | Yes | Yes |
| 15827441 | Multiplexed Analyses of Test Samples | November 2017 | February 2025 | Abandon | 60 | 4 | 1 | No | Yes |
| 15599948 | TD PROBE AND ITS USES | May 2017 | March 2025 | Allow | 60 | 8 | 1 | Yes | Yes |
| 15124977 | DETECTION OF TARGET NUCLEIC ACID SEQUENCES USING DIFFERENT DETECTION TEMPERATURES | September 2016 | January 2025 | Allow | 60 | 8 | 1 | No | Yes |
| 14904170 | DETECTION OF TARGET NUCLEIC ACID SEQUENCE BY PTO CLEAVAGE AND EXTENSION-DEPENDENT IMMOBILIZED OLIGONUCLEOTIDE HYBRIDIZATION | January 2016 | July 2025 | Abandon | 60 | 12 | 0 | Yes | No |
| 14765537 | METHODS FOR SINGLE-MOLECULE ANALYSIS | August 2015 | July 2025 | Allow | 60 | 11 | 0 | Yes | Yes |
| 14409855 | METHOD FOR DETECTING NUCLEIC ACID AND NUCLEIC ACID DETECTION KIT | December 2014 | July 2019 | Allow | 54 | 5 | 0 | Yes | Yes |
| 14284776 | COMPOSITIONS AND METHODS FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISMS | May 2014 | August 2016 | Allow | 27 | 2 | 1 | Yes | No |
| 14226965 | Nucleic Acid Sequences That Can Be Used as Primers and Probes in the Amplification and Detection of All Subtypes of HIV-1 | March 2014 | May 2015 | Allow | 13 | 2 | 0 | Yes | No |
| 14184979 | CANCER ANTIGEN-SPECIFIC T-CELL RECEPTOR GENE, PEPTIDE ENCODED BY THE GENE, AND USE OF THEM | February 2014 | February 2020 | Allow | 60 | 5 | 2 | No | Yes |
| 13572649 | METHOD AND DEVICE FOR DETECTING THE PRESENCE OF A SINGLE TARGET NUCLEIC ACID IN A SAMPLE | August 2012 | July 2013 | Allow | 11 | 2 | 0 | Yes | No |
| 13496546 | NOVEL MOLECULAR BEACONS | May 2012 | August 2018 | Abandon | 60 | 15 | 1 | Yes | Yes |
| 11883150 | RAPID COMPARATIVE GENOMIC HYBRIDIZATION USING ACOUSTIC SURFACE WAVES | October 2008 | July 2011 | Allow | 47 | 2 | 0 | Yes | No |
| 10582820 | SINGLE MOLECULE DETECTION USING MOLECULAR MOTORS | October 2008 | September 2011 | Allow | 60 | 3 | 0 | Yes | No |
| 12206871 | FLUORESCENCE BASED BIOSENSOR | September 2008 | October 2010 | Allow | 26 | 2 | 1 | Yes | Yes |
| 12104506 | EXPRESSION PROFILES FOR PREDICTING SEPTIC CONDITIONS | April 2008 | February 2012 | Allow | 46 | 2 | 1 | Yes | No |
| 12083074 | DNA COLLECTION STICKER AND METHOD FOR ISOLATING DNA FROM THE STICKER | April 2008 | December 2010 | Allow | 32 | 0 | 0 | No | No |
| 12025033 | PAIRED-END READS IN SEQUENCING BY SYNTHESIS | February 2008 | June 2010 | Allow | 28 | 3 | 0 | No | Yes |
| 12004694 | A CHIMERIC PROTEIN COMPRISING A GREEN FLUORESCENT PTOTEIN FUSED TO A TRANSCRIPTION FACTOR | December 2007 | September 2011 | Allow | 45 | 2 | 1 | Yes | Yes |
| 11947119 | PREDICTION OF BARE METAL STENT RESTENOSIS | November 2007 | March 2009 | Allow | 15 | 2 | 0 | Yes | No |
| 11666358 | USE OF THE TRANSCRIPTION OF THE SLUG GENE IN EVALUATING THE REDISPOSITION OF A SUBJECT WITH CANCER TO DEVELOP METASTATIS | November 2007 | March 2010 | Allow | 35 | 3 | 1 | Yes | No |
| 11837565 | METHOD FOR DETECTING THE PRESENCE OF A TARGET NUCLEIC ACID SEQUENCE IN A SAMPLE | August 2007 | June 2014 | Allow | 60 | 4 | 1 | Yes | Yes |
| 11837656 | METHOD FOR DETECTING THE PRESENCE OF A SINGLE TARGET NUCLEIC ACID IN A SAMPLE | August 2007 | May 2012 | Allow | 58 | 4 | 2 | Yes | Yes |
| 11624980 | METHOD OF MANUFACTURING PROBE CARRIER | January 2007 | December 2008 | Allow | 23 | 3 | 0 | No | No |
| 11601516 | DNA FRAGMENTS ARRAY FROM BIOMINING MICROORGANISMS AND METHOD FOR DETECTION OF THEM | November 2006 | November 2010 | Allow | 48 | 2 | 1 | Yes | No |
| 11586363 | METHODS FOR DETECTING CONFORMATIONAL CHANGES IN BIOENTITIES | October 2006 | December 2011 | Allow | 60 | 4 | 1 | Yes | No |
| 11514162 | Carriers having biological substance | September 2006 | January 2015 | Allow | 60 | 6 | 1 | Yes | Yes |
| 11487156 | METHOD FOR DETECTING A MUTATION IN A REPETITIVE NUCLEIC ACID SEQUENCE | July 2006 | April 2011 | Allow | 57 | 3 | 1 | No | No |
| 11427395 | DETECTION METHOD FOR GENE EXPRESSION | June 2006 | November 2010 | Allow | 53 | 3 | 1 | No | Yes |
| 11454478 | FLOW CYTOMETRIC DETECTION METHOD FOR DNA SAMPLES | June 2006 | December 2010 | Abandon | 54 | 5 | 0 | Yes | Yes |
| 11414022 | METHOD FOR HIGHLY SENSITIVE NUCLEIC ACID DETECTION USING NANOPORE AND NON-SPECIFIC NUCLEIC ACID-BINDING AGENT | April 2006 | November 2008 | Allow | 30 | 3 | 1 | No | No |
| 11279711 | HIGH SPEED NUCLEIC ACID SEQUENCING | April 2006 | February 2011 | Allow | 58 | 6 | 0 | Yes | No |
| 11400459 | GHRELIN BINDING NUCLEIC ACIDS | April 2006 | July 2010 | Abandon | 51 | 2 | 1 | Yes | Yes |
| 11277114 | LABELED NUCLEOTIDE PHOSPHATE (NP) PROBES | March 2006 | September 2008 | Allow | 30 | 2 | 0 | Yes | Yes |
| 11336122 | METHODS FOR ANALYZING NUCLEIC ACID SEQUENCES | January 2006 | March 2011 | Allow | 60 | 4 | 0 | Yes | Yes |
| 11173791 | METHODS FOR GENOTYPE SCREENING USING MAGNETIC PARTICLES | June 2005 | November 2008 | Allow | 40 | 3 | 0 | Yes | No |
| 10467033 | METHODS FOR EVALUATING SUSCEPTIBILITY TO A BONE HOMEOSTASIS DISORDER | June 2005 | July 2008 | Allow | 60 | 1 | 1 | No | No |
| 11130801 | METHOD OF DETERMINING BASE SEQUENCE OF DNA OR RNA USING HEAVY ELEMENT LABELING AND IMAGING BY TRANSMISSION ELECTRON MICROSCOPY | May 2005 | December 2006 | Abandon | 19 | 2 | 1 | No | Yes |
| 11108233 | NUCLEIC ACID SEQUENCES THAT CAN BE USED AS PRIMERS AND PROBES IN THE AMPLIFICATION AND DETECTION OF ALL SUBTYPES OF HIV-1 | April 2005 | June 2008 | Allow | 38 | 12 | 1 | Yes | Yes |
| 11087072 | COMPOSITIONS AND METHODS INVOLVING METHYLADENOSINE PHOSPHORYLASE IN THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERS | March 2005 | September 2006 | Allow | 18 | 1 | 1 | Yes | No |
| 11074995 | SYSTEMS AND METHODS FOR TRANSGENIC AND TARGETED MUTAGENESIS SCREENING | March 2005 | August 2007 | Allow | 29 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SISSON, BRADLEY L.
With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 52.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner SISSON, BRADLEY L works in Art Unit 1682 and has examined 103 patent applications in our dataset. With an allowance rate of 66.0%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 46 months.
Examiner SISSON, BRADLEY L's allowance rate of 66.0% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by SISSON, BRADLEY L receive 3.25 office actions before reaching final disposition. This places the examiner in the 91% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SISSON, BRADLEY L is 46 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +23.6% benefit to allowance rate for applications examined by SISSON, BRADLEY L. This interview benefit is in the 70% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 10.9% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 36.5% of cases where such amendments are filed. This entry rate is in the 55% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 82% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 90.9% of appeals filed. This is in the 83% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 90.9% are granted (fully or in part). This grant rate is in the 88% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 20.4% of allowed cases (in the 98% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.9% of allowed cases (in the 83% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.